These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1836743)

  • 21. Light-dark differences in [3H]-paroxetine binding to rabbit platelet membranes.
    Rocca P; Galzin AM; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):41-4. PubMed ID: 2529443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.
    Segonzac A; Schoemaker H; Langer SZ
    J Neurochem; 1987 Feb; 48(2):331-9. PubMed ID: 2947974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
    Kuhs H; Schlake HP; Rolf LH; Rudolf GA
    Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethanol intake and 3H-serotonin uptake. II: A study in alcoholic patients using platelets 3H-paroxetine binding.
    Daoust M; Lhuintre JP; Ernouf D; Legrand E; Breton P; Boucly P
    Life Sci; 1991; 48(20):1977-83. PubMed ID: 1827171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
    Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB
    Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers.
    Maguire K; Tuckwell V; Pereira A; Dean B; Singh B
    Biol Psychiatry; 1993 Sep; 34(6):356-60. PubMed ID: 8218602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seasonal variations in binding of 3H-paroxetine to blood platelets in healthy volunteers: indications for a gender difference.
    Klompenhouwer JL; Fekkes D; van Hulst AM; Moleman P; Pepplinkhuizen L; Mulder PG
    Biol Psychiatry; 1990 Sep; 28(6):509-17. PubMed ID: 2145983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]citalopram binding to brain and platelet membranes of human and rat.
    Plenge P; Mellerup ET
    J Neurochem; 1991 Jan; 56(1):248-52. PubMed ID: 1824783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain.
    Rosel P; Menchon JM; Oros M; Vallejo J; Cortadellas T; Arranz B; Alvarez P; Navarro MA
    J Neural Transm (Vienna); 1997; 104(1):89-96. PubMed ID: 9085196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF; Arora RC; Schreiber MA; Meltzer HY
    Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlorimipramine--but not imipramine--rapidly reduces imipramine--but not paroxetine--binding in human platelets.
    Plenge P; Mellerup ET; Rafaelsen OJ
    Clin Neuropharmacol; 1986; 9 Suppl 4():113-5. PubMed ID: 2952264
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
    Kim SW; Dysken MW; Pandey GN; Davis JM
    Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
    Spigset O; Allard P; Mjörndal T
    Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
    Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
    Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine.
    Cortés R; Soriano E; Pazos A; Probst A; Palacios JM
    Neuroscience; 1988 Nov; 27(2):473-96. PubMed ID: 2975361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional distribution of serotonergic pre- and postsynaptic markers in human brain.
    Laruelle M; Maloteaux JM
    Acta Psychiatr Scand Suppl; 1989; 350():56-9. PubMed ID: 2530792
    [No Abstract]   [Full Text] [Related]  

  • 40. Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.
    Raisman R; Cash R; Agid Y
    Neurology; 1986 Apr; 36(4):556-60. PubMed ID: 2938025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.